Celsia Technologies Taiwan, Inc.
USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F28D (Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact).
The verdict
According to USPTO PatentsView, Celsia ranks #45,541 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.
- #45,541
- of 49,997 US assignees by volume
- 6th percentile
- by Innovation Score (19.4/100)
- 8.8
- avg claims per patent
- +200%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R45541 · Foreign Corporation #45,541 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #45,541/49,997
- PHOTO-FINISH Cellact Pharma
- CPC-NARROW F28D · 5 areas
- INNOV-LOW 19.4/100
- CLAIMS-PAR 8.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +200% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cellact Pharma GMBH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Celsia’s 19.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Celsia
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Celsia Taiwan · this assignee 19
Celsia Taiwan · this assignee
19 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Celsia's Innovation Score is 19.4/100 (6th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Celsia?
Each dot is one of Celsia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Celsia’s own 8.8 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Celsia's grants concentrate
Celsia Technologies Taiwan, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under F28D (Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Celsia sits between Cellact Pharma GMBH and Centicare Corporation.
Who files at Celsia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cellact Pharma
Cellact Pharma GMBH
5 patents
- Cellblock FCS
Cellblock FCS, LLC
5 patents
- Cellomat Israel
Cellomat Israel Ltd.
5 patents
- Celonova Stent
Celonova Stent, Inc.
5 patents
- Cendres+Metaux
CENDRES+METAUX SA
5 patents
- Censhare
Censhare GMBH
5 patents
- Centenary Institu…
Centenary Institute OF Cancer Medicine AND Cell Biology
5 patents
- Centicare
Centicare Corporation
5 patents
- Celsia Taiwan ◀
Celsia Technologies Taiwan, Inc.
5 patents
What this shows Celsia holds 5 patents at rank #45,475, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Celsia
By rank, the assignees closest to #45,475 in granted patent volume.
- Cellact Pharma GMBH #45,471 · 5 patents
- Cellblock FCS, LLC #45,472 · 5 patents
- Cellomat Israel Ltd. #45,473 · 5 patents
- Celonova Stent, Inc. #45,474 · 5 patents
- CENDRES+METAUX SA #45,476 · 5 patents
- Censhare GMBH #45,477 · 5 patents
- Centenary Institute OF Cancer Medicine AND Cell Biology #45,478 · 5 patents
- Centicare Corporation #45,479 · 5 patents
Leaders in F28D (Heat-exchange Apparatus)
Other assignees with the most granted patents in Celsia's primary technology class.
- Hamilton Sundstrand Corporation (HSC) 227 in class
- Mahle International GmbH 187 in class
- Asia Vital Components Co., Ltd. 146 in class
- Hanon Systems 123 in class
- Daikin Industries, Ltd. 113 in class
- Carrier Corporation 109 in class
- Valeo Systemes Thermiques 101 in class
- Alfa Laval Corporate AB 99 in class
Celsia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
19 6th percentile higher than 6% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2020 | 1 | 20.0% |
| 2021 | 2 | 40.0% |
| 2025partial year | 1 | 20.0% |
Which technologies does Celsia Technologies Taiwan, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Celsia Technologies Taiwan, Inc.'s patent record in context - here's where to go next.
- Celsia Technologies Taiwan, Inc.'s lead technology class is F28D (Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact), 80% of its portfolio - see every assignee active in that class. Explore F28D
- Ranked #45,541 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Celsia Technologies Taiwan, Inc. against Cellact Pharma GMBH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 19.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.